JPMorgan Chase & Co. upgraded shares of MorphoSys (NASDAQ:MOR – Get Rating) from an underweight rating to an overweight rating in a research report report published on Friday morning, The Fly reports. JPMorgan Chase & Co. currently has $10.00 target price on the stock, up from their prior target price of $3.30. Separately, UBS Group […]